Huh et al. first perfused the microvascular channel with a clinically relevant dose of interleukin-2 (IL-2), an anti-cancer drug that can cause pulmonary edema (Atkins et al., 1999; Briasoulis and Pavlidis, 2001). This evidence concerns the gene IL2 and pulmonary edema.